Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
COYA compared with GRBK: revenue, margins and what each company keeps, and the suppliers and customers both name
COYA
Coya Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
GRBK
Green Brick Partners, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
COYA
Coya Therapeutics, Inc.
vs
GRBK
Green Brick Partners, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
COYA
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±51.6%
▲
+3.45%
×0.07
GRBK
0 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±9.0%
▼
−0.62%
×0.07
Q2 FY26
±6.7%
▼
−1.96%
×0.30
= implied
COYA realized, solid
GRBK realized, hatched
One scale, both sides: full bar = 52%
× = |realized| ÷ implied
Source: market data
Q1 FY26
±9.6%
▲
+4.39%
×0.46
Q3 FY25
±8.3%
▲
+2.55%
×0.30
COYA
Coya Therapeutics, Inc.
Change
3.25
▲
+0.65%
· post 3.14
Mkt cap
$9.9M
Revenue
$243,745
Q2 FY26
Revenue
$8M
FY25
GRBK
Green Brick Partners, Inc.
Change
63.17
▼
−0.88%
· post 61.79
Closed
Nov 3 '26
Mkt cap
$2.7B
Revenue
$448M
Q3 FY26
Revenue
$2.0B
FY25
vs
Compare
Closed
Nov 3 '26
COYA
Coya Therapeutics, Inc.
vs
GRBK
Green Brick Partners, Inc.
3.25
▲
+0.65%
post 3.14
Price
63.17
▼
−0.88%
post 61.79
$9.9M
Mkt cap
$2.7B
Q2 FY26
$243,745
Revenue
$448M
Q3 FY26
FY25
$8M
Revenue
$2.0B
FY25
Change
Change
COYA
3.25
▲
+0.65%
vs
GRBK
63.17
▼
−0.88%
Closed
Nov 3 '26